ArticleRisks of Future Drugs: A Danish Expert Delphi
Introduction
At the fin de siècle, we are facing what has been called the “second medical revolution” 1, 2, which includes an entirely new generation of drugs13, 4, 5, 6. Drews [7] argues that, after having developed within the “chemical paradigm,” drug research is now under the influence of a radically different approach, the “informational paradigm.” The term “informational” refers to the information provided by our genes. In that respect, modern drug discovery and development is on a journey that is moving deeper into the secrets of the human being. This journey draws parallels to the “first medical revolution” from nature compounds to the chemical paradigm as primary drug approach. We now know that this “first medical revolution” produced risks: we only have to mention the Thalidomide scandal. As a result, drug discovery and development dramatically changed away from an euphoric belief in chemical structures, once it was learned that chemistry can also cause harm to human beings. Today, the “second medical revolution” may produce new types of risks and harm in the future. We had to learn from our mistakes in the first medical revolution and look deeper into the future of risks. Therefore our concern in this study is with the unseen and new side effects that the emergence of the informational paradigm within the field of drugs will undoubtedly bring about [8].
Section snippets
Objective
This study attempts to explore and define the risks2
The delphi method
The Delphi method is perhaps the best known prospective research method in use today [10]. It aims to collect and distill knowledge from a group of experts by means of a series of questionnaires based on a structured process with controlled opinion feedback [11]. According to Lang [12], the development of the Delphi method had its main genesis in two major findings:
- 1.
The “MacGregor effect,” saying that predictions made by a group of individuals are more likely to be right than predictions made by
Response rate and expert demography
A total response rate of 15% in round 1 and 11% in round 2 on the Internet is somewhat lower than the expected response rate for a conventional postal questionnaire (Table 1). Taking into account that the possible expert group was selected as broadly as possible, one might expect that some of the potential experts did not regard themselves as experts on this particular issue. Indeed, this was the argument among those who did not wish to participate.
A relatively low response rate might be a sign
Future drugs
Strategies in future drug discovery and development tend to focus on rational knowledge-based research, rather than on multiple synthesis and the screening of possible lead structures. The optimism about the knowledge-based approach illustrates the trend that the pharmaceutical world has experienced in recent years [6]. Indeed, this approach shows its value because modern diagnosis is able to deal with complex and detailed situations on a molecular level. Information about pathogenesis or
CLAUS MØLDRUP was trained as a pharmacist at The Royal Danish School of Pharmacy, where he is now enrolled as a doctoral student at the Department of Social Pharmacy. His research interests include risk perception, future drugs, prospective research methods, and medical technology assessment.
References (79)
An Evaluation of Delphi
Technological Forecasting and Social Change
(1991)Scientific Inquiry or Political Critique? Remarks on Delphi assessment, Expert Opinion, Forecasting and Group Processes by H. Sackman
Technological Forecasting and Social Change
(1975)Delphi method as a Learning InstrumentBank Employees Discussing an Automation Project
Technological Forecasting and Social Change
(1990)The Design of a Policy Delphi
Technological Forecasting and Social Change
(1970)The Delphi MethodSubstance, Contexts, a Critique and an Annotated Bibliography
Socio-Economic Planning Sciences
(1971)The Anatomy of a Computer Application InnovationComputer Mediated Communications (CMC)
Technological Forecasting and Social Change
(1989)- et al.
Computer-Aided Group Decision Making Theory and Practice
Technological Forecasting and Social Change
(1975) - et al.
The Second Medical RevolutionFrom Biomedicine to Infomedicine
(1987) Twenty-first Century Miracle MedicineRobosurgery, Wonder Cures, and the Quest for Immortality
(1997)Twenty-first Century Medicines
Futures Research Quarterly
(1995)
Drugs and Health in the Year 2000
The Futurist
Intent and Coincidence in Pharmaceutical Discovery
Drug Made in Germany
The Delphi Method and its Contribution to Decision Making
The Knowable FutureA Psychology of Forecasting and Prophecy
Group Decision Making and Disagreement
Social Forces
An Experimental Application of the Delphi Method to the Use of Experts
Delphi
Report on a Long-Range Forecasting Study
Delphi ProcessA Methodology Used for the Elicitation of Opinions of Experts
Delphi and Values
Analysis of the FutureThe Delphi Method
Long Range ForecastingFrom Crystal Ball to Computer
The Delphi Method:Techniques and Applications
Delphi CritiqueExpert Opinion, Forecasting and Group Process
Group Techniques for Program PlanningA Guide to Nominal Group and Delphi Processes
Gazing into the OracleThe Delphi Method and Its Application to Social Policy and Public Health
DelphiA Reevaluation of Research and Theory
Technological Forecasting and Social Change
The Policy Delphi
Forecast to the Year 2015
Research ForesightPriority Setting in Science
Foresight in SciencePicking the Winners
Cited by (0)
CLAUS MØLDRUP was trained as a pharmacist at The Royal Danish School of Pharmacy, where he is now enrolled as a doctoral student at the Department of Social Pharmacy. His research interests include risk perception, future drugs, prospective research methods, and medical technology assessment.
JANINE MARIE MORGALL was trained as a sociologist and received her doctorate at the University of Lund, Sweden. She is the author of the book Technology Assessment—A Feminist Perspective (1993). She is now an Associate Professor at The Royal Danish School of Pharmacy, Department of Social Pharmacy. Her research interests include the sociology of science and technology, medical technology assessment, health care policy, international health care, and risk perception.